HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $23 | -41.0% | 15,409 | 0.0% | 0.00% | – |
Q4 2022 | $39 | -99.9% | 15,409 | 0.0% | 0.00% | – |
Q3 2022 | $65,000 | +51.2% | 15,409 | 0.0% | 0.00% | – |
Q2 2022 | $43,000 | -51.1% | 15,409 | 0.0% | 0.00% | – |
Q1 2022 | $88,000 | -37.6% | 15,409 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $141,000 | -14.5% | 15,409 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $165,000 | -31.0% | 15,409 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $239,000 | -4.4% | 15,409 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $250,000 | -23.3% | 15,409 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $326,000 | +43.0% | 15,409 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $228,000 | +0.4% | 15,409 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $227,000 | +25.4% | 15,409 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $181,000 | +9.0% | 15,409 | +117.8% | 0.00% | 0.0% |
Q4 2019 | $166,000 | +26.7% | 7,074 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $131,000 | -0.8% | 7,074 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $132,000 | -23.7% | 7,074 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $173,000 | -5.5% | 7,074 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $183,000 | -18.3% | 7,074 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $224,000 | – | 7,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|